nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—CYP2B6—Ifosfamide—testicular cancer	0.291	0.332	CbGbCtD
Orphenadrine—CYP2B6—Cisplatin—testicular cancer	0.142	0.161	CbGbCtD
Orphenadrine—CYP2E1—Etoposide—testicular cancer	0.141	0.161	CbGbCtD
Orphenadrine—CYP2B6—Doxorubicin—testicular cancer	0.0949	0.108	CbGbCtD
Orphenadrine—CYP3A4—Ifosfamide—testicular cancer	0.0894	0.102	CbGbCtD
Orphenadrine—CYP3A4—Vinblastine—testicular cancer	0.0474	0.0541	CbGbCtD
Orphenadrine—CYP3A4—Etoposide—testicular cancer	0.0427	0.0487	CbGbCtD
Orphenadrine—CYP3A4—Doxorubicin—testicular cancer	0.0291	0.0332	CbGbCtD
Orphenadrine—Aplastic anaemia—Dactinomycin—testicular cancer	0.00374	0.0304	CcSEcCtD
Orphenadrine—Hallucination—Chlorambucil—testicular cancer	0.00275	0.0224	CcSEcCtD
Orphenadrine—Tremor—Chlorambucil—testicular cancer	0.00226	0.0183	CcSEcCtD
Orphenadrine—Agitation—Chlorambucil—testicular cancer	0.00221	0.018	CcSEcCtD
Orphenadrine—Confusional state—Chlorambucil—testicular cancer	0.00198	0.0161	CcSEcCtD
Orphenadrine—Hallucination—Ifosfamide—testicular cancer	0.00182	0.0148	CcSEcCtD
Orphenadrine—Feeling abnormal—Chlorambucil—testicular cancer	0.00162	0.0132	CcSEcCtD
Orphenadrine—Aplastic anaemia—Methotrexate—testicular cancer	0.00162	0.0132	CcSEcCtD
Orphenadrine—Urticaria—Chlorambucil—testicular cancer	0.00156	0.0127	CcSEcCtD
Orphenadrine—Constipation—Vinblastine—testicular cancer	0.00154	0.0125	CcSEcCtD
Orphenadrine—Confusional state—Bleomycin—testicular cancer	0.00153	0.0125	CcSEcCtD
Orphenadrine—Anaphylactic shock—Bleomycin—testicular cancer	0.00152	0.0124	CcSEcCtD
Orphenadrine—Aplastic anaemia—Epirubicin—testicular cancer	0.00152	0.0123	CcSEcCtD
Orphenadrine—Vision blurred—Ifosfamide—testicular cancer	0.0015	0.0122	CcSEcCtD
Orphenadrine—Feeling abnormal—Vinblastine—testicular cancer	0.00149	0.0121	CcSEcCtD
Orphenadrine—Agitation—Ifosfamide—testicular cancer	0.00146	0.0119	CcSEcCtD
Orphenadrine—Hypersensitivity—Chlorambucil—testicular cancer	0.00145	0.0118	CcSEcCtD
Orphenadrine—Asthenia—Chlorambucil—testicular cancer	0.00141	0.0115	CcSEcCtD
Orphenadrine—Palpitations—Ifosfamide—testicular cancer	0.00141	0.0114	CcSEcCtD
Orphenadrine—Aplastic anaemia—Doxorubicin—testicular cancer	0.0014	0.0114	CcSEcCtD
Orphenadrine—Pruritus—Chlorambucil—testicular cancer	0.00139	0.0113	CcSEcCtD
Orphenadrine—Hypersensitivity—Vinblastine—testicular cancer	0.00133	0.0108	CcSEcCtD
Orphenadrine—Confusional state—Ifosfamide—testicular cancer	0.00131	0.0107	CcSEcCtD
Orphenadrine—Anaphylactic shock—Ifosfamide—testicular cancer	0.0013	0.0106	CcSEcCtD
Orphenadrine—Vision blurred—Cisplatin—testicular cancer	0.0013	0.0105	CcSEcCtD
Orphenadrine—Asthenia—Vinblastine—testicular cancer	0.00129	0.0105	CcSEcCtD
Orphenadrine—Tremor—Cisplatin—testicular cancer	0.00129	0.0105	CcSEcCtD
Orphenadrine—Skin disorder—Ifosfamide—testicular cancer	0.00126	0.0103	CcSEcCtD
Orphenadrine—Feeling abnormal—Bleomycin—testicular cancer	0.00125	0.0102	CcSEcCtD
Orphenadrine—Vomiting—Chlorambucil—testicular cancer	0.00125	0.0102	CcSEcCtD
Orphenadrine—Urticaria—Bleomycin—testicular cancer	0.00121	0.00982	CcSEcCtD
Orphenadrine—Dizziness—Vinblastine—testicular cancer	0.00119	0.00968	CcSEcCtD
Orphenadrine—Feeling abnormal—Dactinomycin—testicular cancer	0.00117	0.0095	CcSEcCtD
Orphenadrine—Nausea—Chlorambucil—testicular cancer	0.00117	0.00949	CcSEcCtD
Orphenadrine—Somnolence—Ifosfamide—testicular cancer	0.00116	0.0094	CcSEcCtD
Orphenadrine—Vomiting—Vinblastine—testicular cancer	0.00115	0.00931	CcSEcCtD
Orphenadrine—Headache—Vinblastine—testicular cancer	0.00113	0.00917	CcSEcCtD
Orphenadrine—Anaphylactic shock—Cisplatin—testicular cancer	0.00112	0.00911	CcSEcCtD
Orphenadrine—Hypersensitivity—Bleomycin—testicular cancer	0.00112	0.00911	CcSEcCtD
Orphenadrine—Constipation—Ifosfamide—testicular cancer	0.00111	0.00904	CcSEcCtD
Orphenadrine—Tachycardia—Cisplatin—testicular cancer	0.00109	0.00889	CcSEcCtD
Orphenadrine—Asthenia—Bleomycin—testicular cancer	0.00109	0.00887	CcSEcCtD
Orphenadrine—Skin disorder—Cisplatin—testicular cancer	0.00109	0.00885	CcSEcCtD
Orphenadrine—Pruritus—Bleomycin—testicular cancer	0.00108	0.00875	CcSEcCtD
Orphenadrine—Feeling abnormal—Ifosfamide—testicular cancer	0.00107	0.00871	CcSEcCtD
Orphenadrine—Nausea—Vinblastine—testicular cancer	0.00107	0.0087	CcSEcCtD
Orphenadrine—Hypersensitivity—Dactinomycin—testicular cancer	0.00105	0.0085	CcSEcCtD
Orphenadrine—Confusional state—Etoposide—testicular cancer	0.00104	0.00842	CcSEcCtD
Orphenadrine—Urticaria—Ifosfamide—testicular cancer	0.00103	0.0084	CcSEcCtD
Orphenadrine—Anaphylactic shock—Etoposide—testicular cancer	0.00103	0.00835	CcSEcCtD
Orphenadrine—Asthenia—Dactinomycin—testicular cancer	0.00102	0.00828	CcSEcCtD
Orphenadrine—Tachycardia—Etoposide—testicular cancer	0.001	0.00815	CcSEcCtD
Orphenadrine—Skin disorder—Etoposide—testicular cancer	0.000998	0.00811	CcSEcCtD
Orphenadrine—Vomiting—Bleomycin—testicular cancer	0.000968	0.00786	CcSEcCtD
Orphenadrine—Drowsiness—Methotrexate—testicular cancer	0.000965	0.00784	CcSEcCtD
Orphenadrine—Hypersensitivity—Ifosfamide—testicular cancer	0.000958	0.00779	CcSEcCtD
Orphenadrine—Asthenia—Ifosfamide—testicular cancer	0.000933	0.00758	CcSEcCtD
Orphenadrine—Feeling abnormal—Cisplatin—testicular cancer	0.000924	0.00751	CcSEcCtD
Orphenadrine—Pruritus—Ifosfamide—testicular cancer	0.00092	0.00748	CcSEcCtD
Orphenadrine—Somnolence—Etoposide—testicular cancer	0.000913	0.00742	CcSEcCtD
Orphenadrine—Nausea—Bleomycin—testicular cancer	0.000904	0.00735	CcSEcCtD
Orphenadrine—Drowsiness—Epirubicin—testicular cancer	0.000903	0.00734	CcSEcCtD
Orphenadrine—Vomiting—Dactinomycin—testicular cancer	0.000903	0.00733	CcSEcCtD
Orphenadrine—Constipation—Etoposide—testicular cancer	0.000879	0.00714	CcSEcCtD
Orphenadrine—Dizziness—Ifosfamide—testicular cancer	0.00086	0.00699	CcSEcCtD
Orphenadrine—Feeling abnormal—Etoposide—testicular cancer	0.000847	0.00688	CcSEcCtD
Orphenadrine—Nausea—Dactinomycin—testicular cancer	0.000843	0.00685	CcSEcCtD
Orphenadrine—Drowsiness—Doxorubicin—testicular cancer	0.000836	0.00679	CcSEcCtD
Orphenadrine—Vomiting—Ifosfamide—testicular cancer	0.000827	0.00672	CcSEcCtD
Orphenadrine—Hypersensitivity—Cisplatin—testicular cancer	0.000826	0.00671	CcSEcCtD
Orphenadrine—Urticaria—Etoposide—testicular cancer	0.000816	0.00663	CcSEcCtD
Orphenadrine—Asthenia—Cisplatin—testicular cancer	0.000805	0.00654	CcSEcCtD
Orphenadrine—Nausea—Ifosfamide—testicular cancer	0.000773	0.00628	CcSEcCtD
Orphenadrine—Hypersensitivity—Etoposide—testicular cancer	0.000757	0.00615	CcSEcCtD
Orphenadrine—Asthenia—Etoposide—testicular cancer	0.000737	0.00599	CcSEcCtD
Orphenadrine—Pruritus—Etoposide—testicular cancer	0.000727	0.00591	CcSEcCtD
Orphenadrine—Vomiting—Cisplatin—testicular cancer	0.000713	0.00579	CcSEcCtD
Orphenadrine—Vision blurred—Methotrexate—testicular cancer	0.000711	0.00577	CcSEcCtD
Orphenadrine—Tension—Epirubicin—testicular cancer	0.000693	0.00563	CcSEcCtD
Orphenadrine—Dizziness—Etoposide—testicular cancer	0.000679	0.00552	CcSEcCtD
Orphenadrine—Nausea—Cisplatin—testicular cancer	0.000666	0.00541	CcSEcCtD
Orphenadrine—Vision blurred—Epirubicin—testicular cancer	0.000665	0.0054	CcSEcCtD
Orphenadrine—Vomiting—Etoposide—testicular cancer	0.000653	0.00531	CcSEcCtD
Orphenadrine—Agitation—Epirubicin—testicular cancer	0.000649	0.00527	CcSEcCtD
Orphenadrine—Headache—Etoposide—testicular cancer	0.000644	0.00523	CcSEcCtD
Orphenadrine—Tension—Doxorubicin—testicular cancer	0.000641	0.00521	CcSEcCtD
Orphenadrine—Palpitations—Epirubicin—testicular cancer	0.000624	0.00507	CcSEcCtD
Orphenadrine—Confusional state—Methotrexate—testicular cancer	0.000621	0.00504	CcSEcCtD
Orphenadrine—Anaphylactic shock—Methotrexate—testicular cancer	0.000615	0.005	CcSEcCtD
Orphenadrine—Vision blurred—Doxorubicin—testicular cancer	0.000615	0.005	CcSEcCtD
Orphenadrine—Nausea—Etoposide—testicular cancer	0.00061	0.00496	CcSEcCtD
Orphenadrine—Agitation—Doxorubicin—testicular cancer	0.0006	0.00488	CcSEcCtD
Orphenadrine—Skin disorder—Methotrexate—testicular cancer	0.000598	0.00486	CcSEcCtD
Orphenadrine—Confusional state—Epirubicin—testicular cancer	0.000581	0.00472	CcSEcCtD
Orphenadrine—Palpitations—Doxorubicin—testicular cancer	0.000577	0.00469	CcSEcCtD
Orphenadrine—Anaphylactic shock—Epirubicin—testicular cancer	0.000576	0.00468	CcSEcCtD
Orphenadrine—Tachycardia—Epirubicin—testicular cancer	0.000562	0.00457	CcSEcCtD
Orphenadrine—Skin disorder—Epirubicin—testicular cancer	0.000559	0.00455	CcSEcCtD
Orphenadrine—Somnolence—Methotrexate—testicular cancer	0.000547	0.00445	CcSEcCtD
Orphenadrine—Confusional state—Doxorubicin—testicular cancer	0.000537	0.00437	CcSEcCtD
Orphenadrine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000533	0.00433	CcSEcCtD
Orphenadrine—Tachycardia—Doxorubicin—testicular cancer	0.00052	0.00423	CcSEcCtD
Orphenadrine—Skin disorder—Doxorubicin—testicular cancer	0.000518	0.00421	CcSEcCtD
Orphenadrine—Somnolence—Epirubicin—testicular cancer	0.000512	0.00416	CcSEcCtD
Orphenadrine—Feeling abnormal—Methotrexate—testicular cancer	0.000507	0.00412	CcSEcCtD
Orphenadrine—Constipation—Epirubicin—testicular cancer	0.000493	0.004	CcSEcCtD
Orphenadrine—Urticaria—Methotrexate—testicular cancer	0.000489	0.00397	CcSEcCtD
Orphenadrine—Feeling abnormal—Epirubicin—testicular cancer	0.000475	0.00386	CcSEcCtD
Orphenadrine—Somnolence—Doxorubicin—testicular cancer	0.000474	0.00385	CcSEcCtD
Orphenadrine—Urticaria—Epirubicin—testicular cancer	0.000458	0.00372	CcSEcCtD
Orphenadrine—Constipation—Doxorubicin—testicular cancer	0.000456	0.0037	CcSEcCtD
Orphenadrine—Hypersensitivity—Methotrexate—testicular cancer	0.000453	0.00368	CcSEcCtD
Orphenadrine—Asthenia—Methotrexate—testicular cancer	0.000442	0.00359	CcSEcCtD
Orphenadrine—Feeling abnormal—Doxorubicin—testicular cancer	0.000439	0.00357	CcSEcCtD
Orphenadrine—Pruritus—Methotrexate—testicular cancer	0.000435	0.00354	CcSEcCtD
Orphenadrine—Hypersensitivity—Epirubicin—testicular cancer	0.000424	0.00345	CcSEcCtD
Orphenadrine—Urticaria—Doxorubicin—testicular cancer	0.000423	0.00344	CcSEcCtD
Orphenadrine—Asthenia—Epirubicin—testicular cancer	0.000413	0.00336	CcSEcCtD
Orphenadrine—Pruritus—Epirubicin—testicular cancer	0.000407	0.00331	CcSEcCtD
Orphenadrine—Dizziness—Methotrexate—testicular cancer	0.000407	0.00331	CcSEcCtD
Orphenadrine—Hypersensitivity—Doxorubicin—testicular cancer	0.000393	0.00319	CcSEcCtD
Orphenadrine—Vomiting—Methotrexate—testicular cancer	0.000391	0.00318	CcSEcCtD
Orphenadrine—Headache—Methotrexate—testicular cancer	0.000386	0.00313	CcSEcCtD
Orphenadrine—Asthenia—Doxorubicin—testicular cancer	0.000382	0.00311	CcSEcCtD
Orphenadrine—Dizziness—Epirubicin—testicular cancer	0.000381	0.00309	CcSEcCtD
Orphenadrine—Pruritus—Doxorubicin—testicular cancer	0.000377	0.00306	CcSEcCtD
Orphenadrine—Vomiting—Epirubicin—testicular cancer	0.000366	0.00298	CcSEcCtD
Orphenadrine—Nausea—Methotrexate—testicular cancer	0.000366	0.00297	CcSEcCtD
Orphenadrine—Headache—Epirubicin—testicular cancer	0.000361	0.00293	CcSEcCtD
Orphenadrine—Dizziness—Doxorubicin—testicular cancer	0.000352	0.00286	CcSEcCtD
Orphenadrine—Nausea—Epirubicin—testicular cancer	0.000342	0.00278	CcSEcCtD
Orphenadrine—Vomiting—Doxorubicin—testicular cancer	0.000339	0.00275	CcSEcCtD
Orphenadrine—Headache—Doxorubicin—testicular cancer	0.000334	0.00271	CcSEcCtD
Orphenadrine—Nausea—Doxorubicin—testicular cancer	0.000317	0.00257	CcSEcCtD
